Saltar al contenido
Merck

Recurrent fixed drug eruption caused by citiolone.

Journal of investigational allergology & clinical immunology (1997-05-01)
M de Barrio, P Tornero, A Prieto, T Sainza, J M Zubeldia, T Herrero
RESUMEN

Citiolone (N-acetylhomocysteinethiolactone) is a thiolic-derived medication frequently used in Spain and in other countries as a mucolytic agent for the treatment of certain hepatic disorders. Mucolytic drugs have rarely been implicated in the fixed drug eruption etiology. We report on a patient who presented several episodes of fixed exanthema related to citiolone intake. The patch test with citiolone (10% in dimethyl sulfoxide) was negative. The diagnosis was confirmed by a positive controlled oral challenge test. Other mucolytic thiolic-derivatives (N-acetylcysteine) were tolerated by the patient, thus crossreactivity between these drugs seems to be unlikely.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
DL-N-Acetylhomocysteine thiolactone, 98%